The United States Food and Drug Administration (FDA) has officially recognized β-Nicotinamide Mononucleotide (NMN) as a lawful ingredient for inclusion in dietary supplements within the United States. This regulatory affirmation follows extensive discourse, scientific scrutiny, and industry advocacy, representing a significant advancement for the global longevity and nutritional science sector.
The decision paves the way for the reinstatement of NMN-containing formulations on major e-commerce platforms that had previously restricted their sale, thereby re-establishing consumer accessibility to one of the most researched and commercially significant longevity compounds in the market.
Naturecan, a global wellness enterprise grounded in evidence-based product development, regards this regulatory shift as a transformative development in the evolution of nutraceutical innovation. According to Paul Holmes, Director of Innovation and Science at Naturecan, “The FDA’s re-evaluation of NMN constitutes a major global benchmark for the scientific and regulatory progression of the nutrition industry.”
Source : https://www.nutraceuticalbusinessreview.com/naturecan-welcomes-fda-approval-nmn-dietary-supplements
